The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3S)-3-acetamido-4-[[(2S)-2-carboxy-3-[1-[[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl]cyclopentyl]propyl]amino]-4-oxobutanoic acid ID: ALA4462603
PubChem CID: 132451821
Max Phase: Preclinical
Molecular Formula: C25H33N3O10
Molecular Weight: 535.55
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)N[C@@H](CC(=O)O)C(=O)NC[C@H](CC1(C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O)CCCC1)C(=O)O
Standard InChI: InChI=1S/C25H33N3O10/c1-14(29)27-18(11-20(31)32)21(33)26-13-16(22(34)35)12-25(8-2-3-9-25)24(38)28-19(23(36)37)10-15-4-6-17(30)7-5-15/h4-7,16,18-19,30H,2-3,8-13H2,1H3,(H,26,33)(H,27,29)(H,28,38)(H,31,32)(H,34,35)(H,36,37)/t16-,18-,19-/m0/s1
Standard InChI Key: ZQIWHIVXBQEYTN-WDSOQIARSA-N
Molfile:
RDKit 2D
38 39 0 0 0 0 0 0 0 0999 V2000
31.2084 -5.0889 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.4965 -5.4975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7847 -5.0889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4965 -6.3188 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.7847 -4.2676 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.0729 -5.4975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2084 -4.2676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9202 -3.8548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9202 -3.0335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6320 -2.6249 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.2084 -2.6249 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.6320 -4.2676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6320 -5.0889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9688 -5.5678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2213 -6.3491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0427 -6.3491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2992 -5.5678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3398 -4.6679 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0520 -5.0726 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.3305 -3.8466 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.7592 -4.6520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4756 -5.0567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1828 -4.6360 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.4848 -5.8779 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.7500 -3.8307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4572 -3.4141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1723 -3.8174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8790 -3.4015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8702 -2.5794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1488 -2.1749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4451 -2.5971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5768 -2.1578 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.0729 -3.8548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0729 -3.0335 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.3610 -4.2676 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0729 -6.3188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3610 -6.7315 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.7847 -6.7315 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 2 0
3 5 1 6
3 6 1 0
1 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
9 11 1 0
8 12 1 1
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 13 1 0
13 18 1 0
18 19 1 0
18 20 2 0
19 21 1 0
21 22 1 0
22 23 1 0
22 24 2 0
21 25 1 1
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 26 1 0
29 32 1 0
5 33 1 0
33 34 2 0
33 35 1 0
6 36 1 0
36 37 1 0
36 38 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 535.55Molecular Weight (Monoisotopic): 535.2166AlogP: 0.25#Rotatable Bonds: 14Polar Surface Area: 219.43Molecular Species: ACIDHBA: 7HBD: 7#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 7#RO5 Violations (Lipinski): 3CX Acidic pKa: 3.40CX Basic pKa: 4.14CX LogP: 0.18CX LogD: -9.39Aromatic Rings: 1Heavy Atoms: 38QED Weighted: 0.17Np Likeness Score: 0.33
References 1. Sharma U, Cozier GE, Sturrock ED, Acharya KR.. (2020) Molecular Basis for Omapatrilat and Sampatrilat Binding to Neprilysin-Implications for Dual Inhibitor Design with Angiotensin-Converting Enzyme., 63 (10): [PMID:32337993 ] [10.1021/acs.jmedchem.0c00441 ]